Technical Analysis for CBMG - Cellular Biomedicine Group, Inc.

Grade Last Price % Change Price Change
grade C 14.9 -2.10% -0.32
CBMG closed down 2.1 percent on Friday, July 10, 2020, on 87 percent of normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Down
Historical CBMG trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Calm After Storm Range Contraction -2.10%
NR7 Range Contraction -2.10%
Wide Bands Range Expansion -2.10%
Overbought Stochastic Strength -2.10%
Down 3 Days in a Row Weakness -2.10%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Cellular Biomedicine Group Inc., a biomedicine company, engages in the development of treatments for cancerous and degenerative diseases in Greater China. The company focuses on developing and marketing cell-based therapeutic products to treat serious chronic and degenerative diseases, including cancer, osteoarthritis, tissue damage, spinal muscular atrophy, various inflammatory diseases, and joint diseases. It is developing treatments utilizing proprietary cell technologies, which include tumor cell specific dendritic cells for the treatment of a range of cancers; human adipose-derived mesenchymal progenitor cells for the treatment of joint disease; human umbilical cord-derived mesenchymal progenitor cells; human embryo-derived motor neuron progenitor precursor cells; and human embryo-derived neuronal progenitor precursor cells for the treatment of central nervous system diseases. The company is headquartered in Palo Alto, California.
Cancer Life Sciences Biology Cancers Stem Cells Tumor Osteoarthritis Inflammatory Diseases Spinal Muscular Atrophy Central Nervous System Diseases Stem Cell Therapy Degenerative Disease Treatment Of Central Nervous System Diseases Mesenchymal Stem Cell

Is CBMG a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 18.99
52 Week Low 10.98
Average Volume 85,636
200-Day Moving Average 15.70
50-Day Moving Average 14.21
20-Day Moving Average 14.74
10-Day Moving Average 15.77
Average True Range 0.80
ADX 24.58
+DI 25.38
-DI 23.79
Chandelier Exit (Long, 3 ATRs ) 14.60
Chandelier Exit (Short, 3 ATRs ) 14.29
Upper Bollinger Band 17.65
Lower Bollinger Band 11.83
Percent B (%b) 0.53
BandWidth 39.54
MACD Line 0.52
MACD Signal Line 0.52
MACD Histogram 0.0063
Fundamentals Value
Market Cap 210.21 Million
Num Shares 14.1 Million
EPS -2.06
Price-to-Earnings (P/E) Ratio -7.23
Price-to-Sales 587.89
Price-to-Book 2.44
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 15.64
Resistance 3 (R3) 15.67 15.47 15.51
Resistance 2 (R2) 15.47 15.28 15.45 15.47
Resistance 1 (R1) 15.18 15.16 15.08 15.15 15.43
Pivot Point 14.98 14.98 14.93 14.96 14.98
Support 1 (S1) 14.69 14.79 14.59 14.66 14.37
Support 2 (S2) 14.49 14.67 14.47 14.33
Support 3 (S3) 14.20 14.49 14.29
Support 4 (S4) 14.17